| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.38 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.26 | 0.09 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |